Rafikov Ruslan, James Joel, McClain Nolan, Tofovic Stevan P, Rafikova Olga
Division of Endocrinology, University of Arizona, Tucson, AZ 85721, USA.
Department of Pharmacology and Chemical Biology, Vascular Medicine Institute, University of Pittsburgh, Pennsylvania, PA 15260, USA.
Antioxidants (Basel). 2019 May 16;8(5):135. doi: 10.3390/antiox8050135.
Pulmonary arterial hypertension (PAH) is one of the diseases with a well-established gender dimorphism. The prevalence of PAH is increased in females with a ratio of 4:1, while poor survival prognosis is associated with the male gender. Nevertheless, the specific contribution of gender in disease development and progression is unclear due to the complex nature of the PAH. Oxidative and nitrosative stresses are important contributors in PAH pathogenesis; however, the role of gender in redox homeostasis has been understudied. This review is aimed to overview the possible sex-specific mechanisms responsible for the regulation of the balance between oxidants and antioxidants in relation to PAH pathobiology.
肺动脉高压(PAH)是一种具有明确性别差异的疾病。PAH在女性中的患病率增加,男女比例为4:1,而男性的生存预后较差。然而,由于PAH的复杂性,性别在疾病发生和发展中的具体作用尚不清楚。氧化应激和亚硝化应激是PAH发病机制中的重要因素;然而,性别在氧化还原稳态中的作用尚未得到充分研究。本综述旨在概述与PAH病理生物学相关的、可能负责调节氧化剂和抗氧化剂平衡的性别特异性机制。